Would you withhold immunotherapy for ES-SCLC during the COVID-19 pandemic?

Risks of COVID-19 infection and severe pneumonia seem to be higher in our patients with lung cancer. This is fairly early data and some of the patients included in those analyses were not receiving any active therapy. This suggests that at least some of the risk is simply frequent visits to the canc...

The current pandemic has posed several challenging questions and forced oncologists to make treatment decisions that they may not have made in normal times, and in this situation making dogmatic statements may be foolhardy. Nonetheless, in patients with extensive stage small cell lung cancer, I woul...